Gloperba
Total Payments
$28,380
Transactions
174
Doctors
154
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $5,313 | 6 | 6 |
| 2020 | $19,318 | 166 | 150 |
| 2019 | $3,750 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,199 | 9 | 46.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,698 | 3 | 27.1% |
| Honoraria | $5,300 | 5 | 18.7% |
| Food and Beverage | $2,184 | 157 | 7.7% |
Ad
Manufacturing Companies
- Avion Pharmaceuticals $28,380
Product Information
- Type Drug
- Total Payments $28,380
- Total Doctors 154
- Transactions 174
About Gloperba
Gloperba is a drug associated with $28,380 in payments to 154 healthcare providers, recorded across 174 transactions in the CMS Open Payments database. The primary manufacturer is Avion Pharmaceuticals.
Payment data is available from 2019 to 2021. In 2021, $5,313 was paid across 6 transactions to 6 doctors.
The most common payment nature for Gloperba is "Consulting Fee" ($13,199, 46.5% of total).